Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36,996 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Advances in EBV Related Lymphoproliferative Diseases.
Lv K, Yin T, Yu M, Chen Z, Zhou Y, Li F. Lv K, et al. Among authors: li f. Front Oncol. 2022 Apr 19;12:838817. doi: 10.3389/fonc.2022.838817. eCollection 2022. Front Oncol. 2022. PMID: 35515118 Free PMC article. Review.
Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z, Hu L, Yao M, He C, Liu Q, Wang F, Gu W, Wang Y, Dong M, Zhu T, Yin T, Li F, Jin Y, Huang S, Zhang H, Sang W; Huaihai Lymphoma Working Group (HHLWG). Shen Z, et al. Among authors: li f. Int J Cancer. 2022 Jan 15;150(2):327-334. doi: 10.1002/ijc.33802. Epub 2021 Sep 24. Int J Cancer. 2022. PMID: 34520566 Free article.
Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201).
Song Y, Zhou K, Jin C, Qian Z, Hou M, Fan L, Li F, Ding K, Zhou H, Li X, Chen B, Sun X, Song X, Jiang M, Zhang Q, Liu L, Yu G, Hu Y, Zhao Z, Liu L, Xue H, Luo J, He B, Jin X, Zhao M, Li B, Xia Y, Zhu J. Song Y, et al. Among authors: li f, li x, li b. Front Oncol. 2022 Jul 7;12:925236. doi: 10.3389/fonc.2022.925236. eCollection 2022. Front Oncol. 2022. PMID: 35875118 Free PMC article.
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China.
Cao XX, Yi SH, Jiang ZX, He JS, Yang W, Du J, Sun CY, Wu Y, Chen WM, Liu XJ, Li BZ, Li CR, Sang W, Liu QH, Chu XX, Li F, Bai O, Mao M, Fu R, Wang W, Liu LH, Wang LQ, Dong YJ, Luo J, Li ZL, Wei YQ, Zhang QK, Liu J, Ding KY, Zou L, Chen BY, Hua LM, Jing HM, He J, Wang L, Li J, Qiu LG. Cao XX, et al. Among authors: li cr, li f, li j, li zl, li bz. Leuk Lymphoma. 2021 Nov;62(11):2657-2664. doi: 10.1080/10428194.2021.1938030. Epub 2021 Jun 9. Leuk Lymphoma. 2021. PMID: 34105439
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
Qiu L, Xia Z, Fu C, Chen W, Chang C, Fang B, An G, Wei Y, Cai Z, Gao S, Weng J, Chen L, Jing H, Li F, Liu Z, Chen X, Liu J, Wang A, Yu Y, Xiang W, Lynch K, Yu Z, Fu W. Qiu L, et al. Among authors: li f. BMC Med. 2022 Apr 5;20(1):108. doi: 10.1186/s12916-022-02305-4. BMC Med. 2022. PMID: 35379237 Free PMC article. Clinical Trial.
36,996 results
You have reached the last available page of results. Please see the User Guide for more information.